AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 10

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.06 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020377IpamorelinMKMMKM-2504-N4424Medutest2025-Q399.425.3492.1Buyer-sourced0PASS
AX-2025-0203635-Amino-1MQMKMMKM-2503-H3929Janoshik2025-Q399.685.5295.1Buyer-sourced0FAIL
AX-2025-020161CJC-1295 with DACERPERP-2506-E9178Janoshik2025-Q399.414.3393.5Buyer-sourced0PASS
AX-2025-019918IpamorelinHJHJ-2504-X6056Janoshik2025-Q399.597.05—Buyer-sourced0PASS
AX-2025-019635BPC-157TFCTFC-2507-J2316Janoshik2025-Q399.013.73104.5Buyer-sourced1MARGINAL
AX-2025-019560TB-500TFCTFC-2503-L9791Janoshik2025-Q399.495.49—Laboratory-retained0PASS
AX-2025-019399CJC-1295 (no DAC)HYBHYB-2504-N7248Janoshik2025-Q399.304.35—Buyer-sourced0PASS
AX-2025-019246CJC-1295 (no DAC)AMBAMB-2507-S5238Kestrel2025-Q399.935.70104.6Buyer-sourced0PASS
AX-2025-019082GHRP-6GSPGSP-2508-F3139Nordanalyt2025-Q399.526.80—Buyer-sourced0PASS
AX-2025-018628TirzepatideQSCQSC-2502-P5432Janoshik2025-Q398.312.34102.0Buyer-sourced0PASS
AX-2025-020614SS-31 (Elamipretide)GL BiochemGLBI-2507-R8080Janoshik2025-Q398.332.81—Buyer-sourced1FAIL
AX-2025-020580TirzepatideSSASSA-2502-D7226PeptideMeter2025-Q398.056.90—Laboratory-retained1MARGINAL
AX-2025-020573TirzepatideSSASSA-2502-D7226Janoshik2025-Q397.896.94—Buyer-sourced1MARGINAL
AX-2025-019974SelankHJHJ-2507-F7054Janoshik2025-Q399.308.74—Buyer-sourced0PASS
AX-2025-019691SelankTFCTFC-2504-G2332VendorInvestigate2025-Q399.028.09104.9Buyer-sourced1MARGINAL
AX-2025-019599IGF-1 LR3TFCTFC-2508-H1748Medutest2025-Q397.765.29103.0Buyer-sourced0PASS
AX-2025-019321TirzepatideAMBAMB-2504-P6263Janoshik2025-Q398.894.94—Buyer-sourced0PASS
AX-2025-018820NAD+FGPFGP-2502-E8063Janoshik2025-Q399.9310.8991.3Buyer-sourced0FAIL
AX-2025-018729SS-31 (Elamipretide)QSCQSC-2502-M6829Medutest2025-Q398.614.22101.5Buyer-sourced1MARGINAL
AX-2025-020998TirzepatideWXTWXT-2505-T3334Janoshik2025-Q397.763.68—Buyer-sourced0PASS
AX-2025-020877BPC-157WXTWXT-2506-M1881PeptideMeter2025-Q399.004.31—Buyer-sourced0PASS
AX-2025-020870IGF-1 LR3WXTWXT-2508-G2536Janoshik2025-Q396.783.4996.0Buyer-sourced0PASS
AX-2025-020728TB-500SGNSGN-2506-M8920Janoshik2025-Q398.478.15—Buyer-sourced2FAIL
AX-2025-020452Melanotan IIKPKP-2508-J5271VendorInvestigate2025-Q397.986.6194.3Buyer-sourced0FAIL
AX-2025-020446Melanotan IIKPKP-2508-J5271Medutest2025-Q398.116.69—Buyer-sourced0FAIL
AX-2025-019768RetatrutideHomopeptideHOMO-2508-U3892Janoshik2025-Q398.726.31—Buyer-sourced0PASS
AX-2025-019577TirzepatideTFCTFC-2507-T1116Janoshik2025-Q397.843.34—Buyer-sourced0PASS
AX-2025-019443MOTS-cJEEPJEEP-2507-W7622Janoshik2025-Q399.564.36—Buyer-sourced2MARGINAL
AX-2025-019245CJC-1295 (no DAC)AMBAMB-2507-S5238Janoshik2025-Q399.666.34103.5Buyer-sourced0PASS
AX-2025-019079GHRP-6GSPGSP-2508-F3139Medutest2025-Q399.576.31—Laboratory-retained0PASS
AX-2025-018859KPVFGPFGP-2506-L8855Janoshik2025-Q399.814.2090.8Laboratory-retained0PASS
AX-2025-018858KPVFGPFGP-2506-L8855Janoshik2025-Q399.913.7191.1Buyer-sourced0PASS
AX-2025-021221MK-677 (Ibutamoren mesylate)PPGPPG-2508-N7944Janoshik2025-Q399.753.89104.6Buyer-sourced0FAIL
AX-2025-020610BPC-157SSASSA-2505-J7334Janoshik2025-Q398.243.11—Buyer-sourced1MARGINAL
AX-2025-020372IpamorelinMKMMKM-2504-N4424Kestrel2025-Q399.365.90102.8Buyer-sourced0PASS
AX-2025-020191SemaglutideERPERP-2502-K9538Medutest2025-Q399.092.94102.7Buyer-sourced0PASS
AX-2025-020167CJC-1295 with DACERPERP-2506-E9178Nordanalyt2025-Q399.115.10106.0Buyer-sourced0PASS
AX-2025-019917IpamorelinHJHJ-2504-X6056VendorInvestigate2025-Q399.166.66—Buyer-sourced0PASS
AX-2025-019913PEG-MGFHJHJ-2507-S5943Nordanalyt2025-Q398.336.64—Buyer-sourced0PASS
AX-2025-019632BPC-157TFCTFC-2507-J2316PeptideMeter2025-Q398.703.61106.1Buyer-sourced2FAIL